Economic burden of type-2 diabetes in Peru: a cost-of-illness study valuing cost differences associated with the level of glycemic control
CONCLUSIONS: T2DM places a heavy burden on the Peruvian healthcare budget that will be even greater if poor glycemic control is maintained.PMID:38584495 | DOI:10.1080/14737167.2024.2333337
Source: Expert Review of Pharmacoeconomics and Outcomes Research - Category: Health Management Authors: Janice Seinfeld Alfredo Sobrevilla Mar ía Laura Rosales Mauricio Ib áñez Delia Ruiz Eduardo Penny Sergio Londo ño Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Health Management | Healthcare Costs | Insurers | International Medicine & Public Health | Peru Health | Stroke | Study